Providing a Clear Path to Market
Corval guides your biopharma team through the commercialization journey, freeing you to focus on innovation.
A Better Approach to Commercialization
When you’re bringing a product to market, there are 1,000 things to think about. But it really all comes down to this: How do you deliver innovative therapies to patients and achieve commercial success while doing so?
Corval knows. Corval’s strategic planning platform organizes and simplifies the complex, fragmented commercialization process. This frees up leaders like you to think big, empowering you to build a plan that ensures goals are met and patients are served.
Powered by over 75,000 data points, Corval’s technology assesses your unique situation and creates a customized map of your path to commercialization.
Informed by decades of experience helping over 100 biopharma companies at all stages forge their path to market.
Designed for collaboration and real-time visibility, Corval facilitates building team consensus around internal insights, assumptions, strategic objectives, and decisions.
Freedom to Lead
Corval bears the burden of process and details, freeing you to focus on driving innovation, creating value, and championing patient needs.
Who it's For
Designed for Early- to Mid-Stage Biopharma Companies
Corval brings a smart, intuitive solution to ease pressures facing young companies:
I Need a Plan
I need an overarching plan that gives me immediate guidance on resources, financing, and critical activities that I can adapt as I learn more while navigating from clinic to market.
I Need to Streamline
I need to consolidate multiple commercialization efforts in one place to reduce the need to manage fragmented resources and systems.
I Need to Build
I need to elevate the capabilities of my high-performing team and build cross-functional alignment to ensure we’re maximizing our efforts to achieve our goals and deliver for patients.
Learn more about how Corval can help your team!
Fill out the form below to request a demo.